NCT07025538 2026-04-20
Biomarker-Guided Ruxolitinib for the Prevention of Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell Transplantation
City of Hope Medical Center
Phase 1 Recruiting
City of Hope Medical Center
Wake Forest University Health Sciences
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Children's Oncology Group
University of Michigan Rogel Cancer Center
Fred Hutchinson Cancer Center
City of Hope Medical Center
Mayo Clinic